Characterization of ADME gene variation in 21 populations by exome sequencing

Hovelson, Daniel H.; Xue, Zhengyu; Zawistowski, Matthew; More

Pharmacogenetics and Genomics . 27(3):89-100, March 2017.

CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case–control study

Figueiras, Adolfo; Estany-Gestal, Ana; Aguirre, Carmelo; More

Pharmacogenetics and Genomics . 26(2):66-73, February 2016.

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202

Verma, Anurag; Bradford, Yuki; Verma, Shefali S.; More

Pharmacogenetics and Genomics . 27(3):101-111, March 2017.

Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

Lubomirov, Rubin; Arab-Alameddine, Mona; Rotger, Margalida; More

Pharmacogenetics and Genomics . 23(1):9-18, January 2013.

Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors

Mahmoudpour, Seyed H.; Veluchamy, Abirami; Siddiqui, Moneeza K.; More

Pharmacogenetics and Genomics . 27(3):112-119, March 2017.

Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case–control study

Hess, Mark W.; de Baaij, Jeroen H.F.; Broekman, Mark M.T.J.; More

Pharmacogenetics and Genomics . 27(3):83-88, March 2017.

Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine

Harris, Michael; Bhuvaneshwar, Krithika; Natarajan, Thanemozhi; More

Pharmacogenetics and Genomics . 24(2):81-93, February 2014.

Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non-small-cell lung cancer patients

Marvalim, Charlie; Wong, Jing Xiang Gimson; Sutiman, Natalia; More

Pharmacogenetics and Genomics . 27(3):120-123, March 2017.

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals

Schmid, Yasmin; Vizeli, Patrick; Hysek, Cédric M.; More

Pharmacogenetics and Genomics . 26(8):397-401, August 2016.

A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration

Lorés-Motta, Laura; van Asten, Freekje; Muether, Philipp S.; More

Pharmacogenetics and Genomics . 26(1):20-27, January 2016.

Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics

Chan, Sze Ling; Samaranayake, Nilakshi; Ross, Colin J.D.; More

Pharmacogenetics and Genomics . 26(1):28-39, January 2016.

HLA-B*57

Falvella, Felicia S.; Cheli, Stefania; Clementi, Emilio

Pharmacogenetics and Genomics . 27(2):81-82, February 2017.

The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response

Lewis, Joshua P.; Horenstein, Richard B.; Ryan, Kathleen; More

Pharmacogenetics and Genomics . 23(1):1-8, January 2013.